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selected APPlIcAtIons of mAss sPectRometRY to stUdY PRoteIns And PRoteomes
Biological objective technique(s) Basic Principles outputs/key characteristics
discover proteins in a 
sample 
DDA As above. Default method for large-scale protein identifi cation and characteriza-
tion. Unbiased but limited reproducibility and quantitative accuracy. 
Can be applied on many different instrument platforms.
DIA As above. Alternative method for large-scale protein identifi cation and charac-
terization. Higher reproducibility and quantitative accuracy than DDA. 
Emerging technique that requires dedicated software for data analysis.
Verify the presence 
of (a) protein(s) in a 
sample
Targeted 
methods
As above. Hypothesis-driven method; lower throughput than shotgun approach 
but better accuracy and lower detection limits; requires triple quadru-
pole-type instruments.
DIA (SWATH) As above. Higher throughput than SRM/MRM, although with somewhat lower 
sensitivity; potential for high to very high proteome coverage from a 
single LC-MS analysis while maintaining accurate quantifi cation.
Verify the presence of 
proteins in a single cell
Mass 
cytometry
Profi ling of target proteins in cell populations using 
antibodies tagged with lanthanide group elements; 
analysis is performed on dedicated elemental mass 
spectrometers (ICP-TOF-MS).
Multiplexed and multiparametric characterization of protein popula-
tions at the single-cell level.
Quantify proteins with-
out stable isotopes
Label-free 
quantifi cation
Quantitative data are derived from the number of MS/
MS spectra per peptide (spectral counting) or the 
integrated peak area of the ion chromatogram of a 
specifi c peptide.
Generally considered less accurate than isotope-based methods but 
does not require expensive labeling reagents; method of choice for 
large numbers of samples; also used for estimating absolute protein 
quantities in a sample. Compatible with all acquisition methods.
Quantify proteins using 
stable isotope labeling
Metabolic or 
chemical isotope 
labeling
Quantitative data are derived from the signal intensity 
ratios of differentially isotope-labeled forms at the 
peptide ion or fragment ion level.
Highest accuracy among quantitative methods, especially in com-
bination with SRM; limited ability for multiplexing; also adaptable to 
absolute quantifi cation if one isotopic form of a peptide is a reference 
in known amounts. Compatible with all acquisition methods.
detect Ptms DDA, DIA,
targeted 
analysis
Use of dedicated isolation or fractionation schemes 
to isolate or enrich peptides carrying posttranslational 
modifi cations, for example, phosphorylation, glycosyl-
ation, or ubiquitination, prior to their MS analysis.
Presence and (ideally) residue-level localization of modifi cations;  
composition of structurally complex modifi cations (e.g., glycosyl-
ation).  
detect proteolytic 
processing
DDA, DIA, 
targeted 
analysis
Selective isolation of peptides from the protein N termini 
(or, less frequently, C termini) using labeling and affi nity 
techniques to detect protein processing.
Processing sites of endogenous proteases; signal peptides.
determine the con-
stituents of a protein 
complex
Affi nity 
purifi cation 
(AP)-MS
Isolation of protein complexes under (near-)native 
conditions using affi nity-tagged target (bait) proteins; 
interacting proteins are then identifi ed by bottom-up 
MS techniques.
Composition and stoichiometry of protein complexes; higher-order 
association of proteins into modules and networks.
determine changes in 
protein conformation
Hydrogen/
deuterium exch-
ange (HDX)-MS; 
chemical/radical 
footprinting
HDX: Exchange of hydrogen atoms of the amide bonds 
in proteins and protein complexes to deuterium is moni-
tored by MS; Footprinting: Solvent accessible sites are 
probed by covalent labeling, e.g., by radical-induced 
oxidation.
Identifi cation of conformational changes; ligand-binding sites (e.g., 
epitopes).
characterize protein 
complexes on the 
molecular level
Native MS, ion 
mobility spectro-
metry (IMS)
Analysis of intact protein complexes in the mass spec-
trometer with or without combination with ion mobility 
separation.
Composition and stoichiometry of protein complexes; conformation/
shape (IMS) and changes thereof.
determine the subunit 
connectivity of complex 
components
Crosslinking 
(XL)-MS
Introduction of artifi cial covalent bonds using chemical 
crosslinking reagents; crosslinked proteins are then 
analyzed by different bottom-up MS techniques.
Spatial proximity of domains within a protein or of subunits in a com-
plex; binary contacts and low-resolution distance information.
characterize proteins 
on the cell surface
Cell-surface 
capture
Analysis of cell-surface proteins by affi nity labeling and 
enrichment of accessible surface (glyco)proteins.
Specifi c enrichment of a protein subpopulation that is highly enriched 
in drug targets.
localize the distribu-
tion of proteins in 
tissue
MS imaging Analyzing the spatial distribution of molecules (includ-
ing peptides and proteins) directly from tissue speci-
mens (typically by MALDI) or cells (by secondary ion 
MS [SIMS]).
Spatial distribution; tissue classifi cation; biomarker measurement.
mAIn concePts of dAtA AcQUIsItIon In mAss sPectRometRY-BAsed PRoteomIcs
ms technique description
data-dependent 
acquisition (ddA)
Molecular ions of intact peptides are selected automatically and in real time for gas-phase fragmentation from the molecular ions detected in a 
survey scan, using criteria such as signal intensity and charge state. Data acquisition is performed in iterative cycles of survey and fragment ion 
scans. The method is most frequently used on complex peptide samples generated by sample proteolysis (bottom-up mode) and less frequently 
on intact proteins (top-down mode). Due to the stochastic nature of peptide ion selection, the method is also referred to as shotgun proteomics.
targeted data
acquisition
Molecular ions of predetermined peptides are selected and gas-phase fragmented. The signal intensities of predetermined fragment ions unique 
to the targeted peptide(s) (transitions) are recorded over time by a method called selected reaction monitoring (SRM), or multiple reaction moni-
toring (MRM). The instrument cycles through the list of predetermined peptide ion lists and their transitions. 
data-independent 
acquisition (dIA)
Several to many peptide ions are concurrently selected and fragmented, and the composite fragment ion spectra are recorded. Specifi c imple-
mentations include MSE, in which peptide ions are selected in a single wide m/z range (typically 800 m/z), and SWATH-MS, in which peptide 
ions are sequentially isolated in smaller mass windows (typically 25 m/z). In both cases, composite fragment ion spectra of all peptides in a 
sample are recorded that then need to be deconvoluted.
others Techniques that do not follow the basic acquisition strategies, such as MS imaging or mass cytometry.
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Mass spectrometry (MS) is the key technology in contemporary proteomics research. Therefore, it has enabled major contributions to identifying, quantifying, and characterizing 
the proteome. In this SnapShot, we give a brief overview of current and emerging mass spectrometric methods. While MS is a generic analytical technique, this article is focused 
on the application of MS to determine the various features of a proteome.
At the very fundamental level, a mass spectrometer measures the mass-to-charge ratio (m/z) of ions generated by one of a range of different ionization techniques. For most 
proteomics applications, electrospray ionization (ESI) is used to produce ions from a liquid phase, such as the eluent from a liquid chromatography column. Matrix-assisted laser 
desorption/ionization (MALDI) is an alternative ionization technique that generates ions from samples on a solid phase. Different physical principles are used to separate, detect, 
and count the thus generated ions and to determine their m/z ratio. Common analyzer types in mass spectrometers include quadrupoles, ion traps, time-of-flight devices, and 
orbitraps. Mass spectrometers may use a single analyzer type or a combination of two or more different analyzers in sequence. For sample introduction, the mass spectrometer 
is usually operated as an integrated system that is hyphenated with liquid chromatography (LC-MS).
For the analysis of proteins and proteomes, MS has been used in two fundamentally different ways. In the first, referred to as top-down proteomics, intact proteins (and their 
fragment ions) are used to analyze the primary structure of a protein. The second and almost exclusively used approach is referred to as bottom-up proteomics. There, intact 
proteins are first cleaved, usually by enzymatic digestion, into peptides, and these peptides are the analytes that are analyzed by MS. A multitude of bottom-up MS techniques 
have been developed to identify and quantify proteins, to determine PTMs, and to characterize protein complexes.
Because the m/z and, by inference, the mass of a peptide is not sufficient to infer its sequence and thus its identity, most mass spectrometers used in proteomics are capable 
of performing fragmentation to break peptide ions into smaller parts that provide additional evidence for their identification (tandem mass spectrometry, MS/MS). Fragmenta-
tion can be induced by collisions with gases (collision-induced dissociation) or, less commonly, via interaction with electrons (for example, in electron-transfer dissociation). 
The general fragmentation behavior of peptide cations is reproducible and, to some extent, predictable. Therefore, MS/MS spectra of specific peptides can be interrogated by 
computer algorithms to assign the corresponding peptide sequence.
Current mass spectrometers are capable of generating huge amounts of data that require powerful software for their analysis. For example, the fastest instruments are 
capable of acquiring tens of MS/MS spectra per second, and data files can be generated at a rate exceeding 1 gigabyte per hr. Bioinformatic tools for data analysis benefit from 
the wealth of information provided by MS, enabling not only protein identification and quantitation, but also the analysis of posttranslational modification and processing and the 
elucidation of protein complex structure and interaction networks.
In addition to different implementations of classical bottom-up mass spectrometry for protein identification and characterization, a variety of complementary MS techniques 
are increasingly applied to generate additional biological knowledge. These include methods for the analysis of higher-order protein structure such as protein fold and the asso-
ciation into protein complexes, protein localization in a cell or tissue, and others. For these applications, intact proteins, protein complexes, or suitable subcellular fractions may 
be directly interrogated. In the emerging technique of mass cytometry, even whole cells are introduced into the mass spectrometer.
Abbreviations
ESI, electrospray ionization; ICP, inductively coupled plasma; IMS, ion mobility spectrometry; LC-MS, liquid chromatography-mass spectrometry; MALDI, matrix-assisted laser 
desorption/ionization; MS, mass spectrometry; PTM, posttranslational modification; SIMS, secondary ion MS; SWATH, sequential windowed acquisition of all theoretical mass 
spectra; TOF-MS, time-of-flight MS.
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